South African President Cyril Ramaphosa, while welcoming an offer by telecoms firm MTN to donate US$25 million to the vaccine programme of the AU’s disease control body to immunise healthcare workers, called on more firms to do the same, and asked more countries to support an initiative to waive intellectual property rules affecting vaccine production. Ramaphosa said that it was a “painful irony” that some Covid-19 vaccine trials had taken place in Africa, but that it was still struggling to secure doses and said that if a push by India and South Africa at the World Trade Organisation to waive parts of the TRIPS agreement on intellectual property rights succeeds, African countries could benefit from technology transfer to manufacture vaccines more cheaply.